UK Covid News
Isolation changes, game changing drugs and more
The business owners we talk to are all super-keen to keep going through the pandemic. They’re the trailblazers, the innovators, the front-liners. They’ve tried every method available to keep going. They’ve put in place anti-virus protections and procedures. They’ve fought to survive... and they’re still fighting.
We salute you.
As we enter 2022, effectively the third year of the pandemic, humanity’s store of knowledge about covid keeps growing and changing, along with the virus itself. Here are some of the latest facts about the illness that’s changing our world forever.
7 day isolation is almost as good as 10 days
If you’ve tested positive in England you’ll need to isolate for seven rather than the original ten days, as long as you’ve had two negative rapid lateral flow tests, one on day six of your isolation and the second on day 7. On the other hand officials say you should still work at home if possible, avoid crowds, and take huge care around vulnerable people. If you haven’t been fully vaccinated and you’re isolating because you’ve encountered someone who has tested positive, you still need to isolate for the full 10 days.
UK focuses on drugs designed to prevent severe covid
We predict drugs like sotrovimab, molnupiravir and Paxlovid will become household names through 2022, used soon after infection to prevent serious symptoms in high risk people. The first covid antiviral pill can already be taken at home, and the most vulnerable of all can ask for antibody infusions the moment they test positive.
2021 has seen new treatments developed to protect people when they first become infected and their symptoms are mild. Everyone’s hoping this will mean people get less poorly and fewer need to go to hospital. The UK National Institute for Health Research says these drugs are ‘potentially game-changing’.
- The intravenous therapy sotrovimab harnesses a man-made antibody that blocks the virus. It can protect you from re-infection for at least 4 weeks as well as reducing severe symptoms.
- The oral treatment molnupiravir looks likely to cut hospital admissions by 30% when taken within 5 days of infection. Molnupiravir can’t be used by pregnant or breastfeeding women and there are some concerns around the drug kicking off another variant, simply because it works by forcing multiple viral mutations that kill the virus.
- Paxlovid is another antiviral pill. With luck it might cut the risk of developing severe covid by almost 90% by blocking an enzyme covid needs to reproduce. It’s under review in the UK at the moment, not yet in use, although the FDA approved it for use in the USA on 22nd December.
New variants are unavoidable
It isn’t a matter of if, it’s a matter of when. While vaccines will remain at the heart of humanity’s battle against covid, the inevitable new variants we’ll see in future make the treatments for covid we’ve talked about vitally important. And there are more on the way – including the long-acting antibody injection Evusheld.
Snippets of covid news from around the world
- Israel is offering people fourth dose of covid vaccine to health workers, those over 60, and people with weak immune systems who had their third shot at least four months ago
- Omicron is the dominant coronavirus variant in the US
- England stands out as remaining mostly open against a landscape where most countries are taking extra covid precautions. The scientific community is very concerned and some say we’re living in a giant petri-dish, being subjected to an enormous medical experiment
- The Welsh government announced a ban on spectators at sporting events from 26th December
- The Mayor of London has cancelled New Year celebrations in Trafalgar Square
- The EU has authorised another vaccine, this time by Novavax, designed for 18s and over. It’s the 5th vaccine they’ve approved
- Italy has banned New Years Eve celebrations, and banned all concerts and open air events until the end of January in an effort to curb omicron
- Australia plans to close the gap between second doses and boosters from five months to four months on 4th January, then again to three months at the end of January
It’s time to get our UVC covid killer robots on the case!
This is a traditional time of year for reflection. Covid has been affecting businesses since March 2020, now it’s 2022. This is our world, and no scientist would claim covid is going to go away. It’s here for good and until we learn to live with it in an effective way, your business needs to offer a good level of safety to employees, visitors, suppliers and customers. Let’s talk about how a UVC covid killing robot will keep your premises safe and clean.









